HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCPC Statement On Cosmetics Reform Legislation Hints At Potential Compromises

This article was originally published in The Rose Sheet

Executive Summary

The Personal Care Products Council outlines a list of “principles” that it believes should guide legislation to update cosmetics regulations. Many of its priorities could be seen as aligning more closely with reintroduced House legislation than the less industry-friendly Personal Care Products Safety Act in the previous Senate, signaling a possible change in strategic direction at PCPC under the new Administration.

You may also be interested in...



Rep. Pallone's Push For Cosmetics Reform Falls Flat During OTC Monograph Bill Markup

The New Jersey Democrat introduced multiple cosmetics-related amendments during the House Health Subcommittee's markup of draft OTC monograph reform legislation. While ultimately nothing came of the proposed measures, it's clear that Pallone remains intent on updating cosmetics regulations to require facility registration, adverse event reporting and good manufacturing practices, among other aims.

Oregon Collecting First Biennial Notices, Fees From Children's Cosmetic Marketers

Under the Toxic-Free Kids Act, notifications and fees are due to the Oregon Health Authority by the start of the new year from manufacturers of children's products that contain state-listed ingredients or contaminants. The Rose Sheet examines how Oregon's chemical reporting program, and others like it around the US, would be impacted by preemption clauses in proposed federal legislation to update cosmetics regulations.

ICMAD Stands By House Cosmetics Bill, But May Be Ready To Negotiate

The Independent Cosmetic Manufacturers and Distributors calls Republican Senator Orrin Hatch's FDA Cosmetic Safety and Modernization Act "a step in the right direction," echoing the Personal Care Products Council's take on the proposal, signaling potential for industry solidarity at an auspicious moment in Washington.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109040

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel